Outlook gains as wet AMD therapy reconsidered for FDA review

2 Financials Stocks to Keep an Eye On and 1 We Find Risky

2026/08/16

Just 13% of U.S. large-cap stock-picking funds beat benchmarks over decade

2026/08/16

3 Industrials Stocks Walking a Fine Line

2026/08/16

1 S&P 500 Stock Worth Investigating and 2 We Turn Down

2026/08/16